Nutex Health Inc. (NUTX) SEC Filings & Earnings Calls

Cybersecurity event could lead to data breach liabilities, remediation costs, and reputational damage.

“Update on a previously announced cyber security event.” · word for word

Data breach exposes company to litigation, regulatory penalties, reputational damage, and potential loss of patient/employee trust.

“the Company believes that certain information maintained on the Company's servers was accessed and exfiltrated by an unauthorized third party, including patient and employee, credentialed provider, business and financial information that is private and/or confidential.” · word for word

Data breach may lead to regulatory fines, litigation, and reputational damage.

“Unauthorized access and exfiltration of private/confidential information; ongoing investigation.”

Regulatory uncertainty remains as new rules must be promulgated.

“Court directed Departments to exercise enforcement discretion until new rules.”

Revenue decline due to prior year IDR benefit; reliance on arbitration for profitability.

“Revenue decreased 13.6% due to positive IDR results in prior year.”

Revenue decline due to variable consideration adjustments

“This decrease was primarily attributed to positive adjustments to variable consideration realized in 2025 as we experienced early success with the IDR process.” · word for word

Dependence on favorable arbitration and regulatory outcomes

“Based upon current expectations, we anticipate the impact of these favorable changes will lead to an approximate 25-30% reduction in our normalized historical contract services prospectively. This impact is based on the current regulatory outlook and the Company’s current expectations, and actual contract services expenses incurred in the future may differ s” · word for word

Stock-based compensation volatility

“Stock-based compensation contributed significantly to the increase in Adjusted EBITDA in the 2026 period.” · word for word

Dependence on HaloMD for dispute resolution; new right to use in-house or other vendors mitigates.

“Company may perform dispute resolution services in-house or through another vendor.”

Arbitration cost volatility

“The decrease is primarily driven by the total cost of arbitration, which for all Nutex hospital and professional services for the three months ended March 31, 2026 and 2025 was $46.1 million and $26.3 million, respectively.”

Same-hospital visit growth stagnation

“Visits at same hospitals, which are hospitals that were opened by December 31, 2024, increased an average of 0.6% versus prior year.” · word for word

Dependence on IDR process for revenue; arbitration costs ~35% of arbitration-related revenue.

“arbitration costs approximating 35% of arbitration-related revenue” · word for word

Stock-based compensation volatility; negative $3.9M in Q1 2026 vs $27.6M in Q1 2025.

“Total stock-based compensation expense... was $(3.9) million, compared to $27.6 million for the same period in 2025”

Related-party conflict of interest with CEO

“In addition to its respective non-affiliate doctor owners, each Real Estate Entity is partially owned or controlled by Dr. Vo, our Chairman, CEO and major stockholder.” · word for word

Significant potential dilution from earn-out shares

“Based on the formula described above, and assuming an aggregate 1,361,861 shares issued, the earn out shares will represent approximately 19.2% of outstanding shares as of December 31, 2025.” · word for word

Dispute over earn-out share calculation

“Former owners of certain under construction hospitals have disputed the number of additional shares issuable to them in accordance with the formula agreed upon at the time of the merger (as described above) and assert, among other things, that the number of shares in the calculation should not be adjusted for the 2024 reverse stock splits.” · word for word

Q4 revenue impacted by $55M arbitration true-up; reliance on IDR process for revenue.

“One-time $55.0 million cumulative true-up of 18,950 arbitration claims deemed ineligible.” · word for word

High stock-based compensation ($117M) impacts net income.

“Total stock-based compensation expense for the twelve months ended December 31, 2025 was $117.0 million.” · word for word

Regulatory Compliance Risk

“If our operations are found to be in violation of any of such laws or any other governmental regulations that apply, we may be subject to significant penalties.” · word for word

IDR Process Dependency

“Our revenue for 2025 was positively affected by an increase in revenue per visit due to success in efforts to obtain higher rates through the IDR process.” · word for word

Stock-Based Compensation Dilution

“Higher stock-based compensation in the form of one-time obligations of earn-out shares issuable to qualifying under construction and ramping hospitals of $117.0 million for 2025.” · word for word

Dependence on arbitration revenue (IDR process) for ~70% of hospital revenue; arbitration costs 24-26% of related revenue; regulatory or legal changes could impact sustainability

“Of the $260.2 million in hospital revenue, $182.1 million (or approximately 70.0%) related to a combination of both higher acuity claims as well as success through the Independent Dispute Resolution (IDR) process. Arbitration costs approximate 24-26% of the arbitration related revenue.” · word for word

High stock-based compensation ($13.2M in Q3) due to one-time obligations for under-construction hospitals, diluting shareholders

“Total stock-based compensation expense for the three months ended September 30, 2025 was $13.2 million compared to $2.0 million for the same period in 2024. Approximately 99.5% of total stock-based compensation expense of $13.2 million is due to the one-time obligations for under-construction and ramping hospitals.” · word for word

Stock-Based Compensation Volatility

“Higher stock-based compensation to under construction and ramping hospitals of $13.2 million for the three months ended September 30, 2025, an increase of $11.3 million compared to the same period last year.” · word for word

Concentration Risk in Hospital Division

“Hospital division revenue represents 97% of total revenue, making the company highly dependent on this segment.”

Material weakness in internal control over financial reporting

“We previously reported an additional material weakness in the design and operating effectiveness of internal control over financial reporting... related to the accounting treatment of obligations associated with under-construction and ramping hospitals.” · word for word

IDR Process Sustainability Risk

“The IDR process can take up to three to five months to receive payments relative to the start of a claim’s open negotiation process.” · word for word

Regulatory and Legal Uncertainty

“There are numerous continuing legal challenges to the federal regulations promulgated under the NSA, in particular those mandating the methodology of calculating the qualifying payment amount and implementing the independent dispute resolution process, creating significant uncertainty in the claims recovery process.” · word for word

New Facility Start-up Losses

“Our operating income was adversely impacted by $8.4 million from the opening of four new hospital locations in 2024.” · word for word

Material Weakness in Internal Controls

“We have identified material weaknesses in our internal control over financial reporting.” · word for word

Massive dilution risk from additional share issuance to former owners of under-construction hospitals

“Our obligation to issue additional shares of our common stock to former owners of under construction hospitals may cause significant dilution of our current stockholders.” · word for word

Litigation risk from securities class action and derivative lawsuits

“On August 22, 2025, a putative securities class action complaint was filed against the Company following the publication of a short-seller report.” · word for word

NASDAQ non-compliance risk

“On August 20, 2025, the Company received a notice from NASDAQ regarding non-compliance with continued listing requirements as a result of the delayed filing of its Form 10-Q for the period ended June 30, 2025.” · word for word

Restatement indicates prior accounting errors in classification of stock compensation and related-party transactions, though non-cash and immaterial to key metrics

“Corrected the classification of non-cash, stock-based compensation obligations totaling $20.7 million related to under construction and ramping hospitals from equity to liabilities. Reclassified related-party accounts payable balances of $3.5 million from liabilities to equity.” · word for word

High stock-based compensation ($27.6M in Q1) continues to distort GAAP net income

“Total stock-based compensation expense for the three months ended March 31, 2025 was $27.6 million compared to less than $0.1 million for the same period in 2024. Approximately 99% of total stock-based compensation expense of $27.6 million is due to the one-time obligations for under-construction and ramping hospitals.” · word for word

Restatement indicates prior accounting errors in classification of stock compensation and related-party transactions, though non-cash and immaterial to key metrics

“Corrected the classification of non-cash, stock-based compensation obligations totaling $16.4 million related to under construction and ramping hospitals from equity to liabilities. Net income for the year decreased by approximately $0.5 million (0.5%).” · word for word

Stock-based compensation ($16.6M in FY2024) remains significant, though lower than subsequent quarters

“Total stock-based compensation expense for the year ended December 31, 2024 was $16.6 million, compared to $2.8 million for the same period in 2023. Approximately 99% of total stock-based compensation expense of $16.6 million was due to one-time obligations for under-construction and ramping hospitals.” · word for word

High stock-based compensation ($78.7M in Q2) due to one-time obligations for under-construction hospitals, causing net loss despite strong operations

“Total stock-based compensation expense for the three months ended June 30, 2025 was $78.7 million, an increase of approximately $78.8 million compared to the same period in 2024. Approximately 99% of total stock-based compensation expense of $78.7 million is due to the one-time obligations for under-construction and ramping hospitals.” · word for word

Negative EBITDA (-$0.5M) in Q2 due to stock comp; reliance on adjusted EBITDA for profitability picture

“EBITDA attributable to Nutex Health of $(0.5) million, as compared to EBITDA attributable to Nutex Health of $8.5 million for the three months ended June 30, 2024, a decrease of 105.4%.” · word for word